Tag: Cancer: Lung
RSNA: 20-Year Survival Shows Lung Cancer Screening Effective
Furthermore, consistency of lung cancer may be an important predictor of survival
More Frequent Scans Not Linked to Improved Survival After Lung Cancer Surgery
More frequent surveillance not linked to longer recurrence-free, overall survival in pathologic stage I non-small cell lung cancer
Decrease Noted in Lung Cancer Cases Over Past Five Years
However, screening of high-risk individuals for lung cancer is still low at 5.8 percent nationally
FDA Approves Drug Combo for Metastatic Non-Small Cell Lung Cancer
Approval is for tremelimumab in combination with durvalumab and platinum-based chemotherapy
Top Medical Groups, Hospitals Urge Better Access to Lung Cancer Screening
More than 50 cancer groups have issued an urgent call for more lung cancer screening among high-risk people
Adherence to Annual Follow-Up Lung Cancer Screening Low
Only 22.3 percent of those with an initial LDCT had a repeat annual LDCT; 34.3 percent adherent with follow-up to 24 months
Risk Factors ID’d for New Long-Term Opioid Use After Lung Cancer Surgery
New long-term opioid use associated with increased risk for two-year all-cause mortality, especially for potent opioid use
AI Model Can Help Segment NSCLC Tumors on CT Images
Reduced segmentation time, interobserver variability seen with artificial intelligence assistance in segmentation for radiotherapy targeting
Pathogenic Germline Variants ID’d in Patients With Lung Cancer
About 15 percent of patients diagnosed with lung cancer had PGVs, most of which were potentially clinically actionable
Tabrecta Gains Full FDA Approval for Non-Small Cell Lung Cancer
Drug approved for non-small cell lung cancer with mutation leading to MET exon 14 skipping
